FIELD: medicine.
SUBSTANCE: invention can be used for treating an individual suffering ulcerative colitis. That is ensured by administering an effective amount of an antigen composition containing whole killed E. coli cells. Composition is applied either intracutaneously or subcutaneously in the form of serially administered doses with a dose interval of at least one hour.
EFFECT: invention provides use of an anti-inflammatory composition for treating an ulcerative colitis in an individual.
13 cl, 48 dwg, 10 tbl, 13 ex
